Logo

Ajanta Pharma Ltd. Share Price

Pharmaceuticals & Drugs

Ajanta Pharma Ltd. (INR)2706.1-59.7   (-2.2%)

Exchange ScripsBSE532331NSEAJANTPHARMISININE031B01049

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Ajanta Pharma Ltd. Performance

Market performance

Open price2781.4
High2781.4
Volumes96395
Prev Close2706.1
Low2679.8
Closing date2025-04-30

Historical performance

1 Year High3485.00
3 Year High3485.00
5 Year High3485.00
1 Year Low2111.05
3 Year Low1061.77
5 Year Low887.33

Ajanta Pharma Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
34689
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
41.74
Dividend Yield
Dividend Yield
0.94 %

Ajanta Pharma Ltd. Investment Returns

1 Year
22.1%
3 Years
135.8%
5 Years
172.9%
10 Years
221.4%

Ajanta Pharma Ltd. Technicals

IndicatorsValueSignal
5-DMA2742.7Bearish
10-DMA2709.35Bearish
20-DMA2629.3Bullish
50-DMA2612.03Bullish
100-DMA2722.46Bearish
200-DMA2854.2Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters88888
Foreign Investors---------------
Domestic Investors88888
Public Investors7081966888643077030855480
Government1111---

Ajanta Pharma Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income8469861157260
Operating Profit1256588191045010245
Interest725810283
Depreciation1354130812531161
Profit Before Tax11139745290959002
Consolidated Net Profit8162588071276539
Adjusted EPS65475650

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital253253172174
Total Reserves35364336243246929777
Minority Interest------------
Total Non-Current Liabilities408177428502745
Total Liabilities45039470464196841090
Capital Work in Progress2565209515291082
Total Assets45039470464196841090

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities7851792156175763
Cash Flow from Investing Activities654-5596-741-2824
Cash Flow from Financing Activitie-10511-1082-4597-3183
Net Cash Inflow / Outflow-20061243279-244
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 41.74.
  • 3Y Stock Price CAGR of the stock is 31.1.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹12565 Million.
  • The company generated revenue of ₹42087 Million in the previous financial year.

Ajanta Pharma Ltd.

2706.1-59.7   (-2.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1211325
No. of Shares: 447.6
Performance:21.1%
P/L: ₹211325

Top Gainers

SymbolChange%
SONATSOFTW421.55(12%)
ABINFRA88.96(11%)
GLOBALVECT220.9(10%)
VMM118.48(10%)
JETFREIGHT14.77(10%)

Top Losers

SymbolChange%
PREMEXPLN416.2(-11%)
PRAJIND461.3(-9%)
GTECJAINX25.6(-9%)
MADHUCON6.85(-8%)
AMBICAAGAR26.8(-8%)
GSS37.6(-8%)
OSWALAGRO78.03(-8%)
WALCHANNAG180.82(-8%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

60.1

53.65

March 30 - April 30

Hester Biosciences Ltd.

42.1

1782.9

March 30 - April 30

Sakar Healthcare Ltd.

28.3

271.56

March 30 - April 30

Valiant Laboratories Ltd.

25.9

96.4

March 30 - April 30

Morepen Laboratories Ltd.

25.8

60.17

March 30 - April 30

Panacea Biotec Ltd.

25.1

552.15

March 30 - April 30

Brooks Laboratories Ltd.

24.2

132.1

March 30 - April 30

Bal Pharma Ltd.

21.8

102.15

March 30 - April 30

Announcing Stock of the Month!

Stock of the Month
Stock of the Month